Insmed Inc (INSM): Cash & Equivalents
$510.44M
As of 2025-12-31
$544.76M
As of 2026-06-30
-22.0%
3-year compound annual growth
-0.9%
5-year compound annual growth
+6.1%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $510.44M | -8.0% | 2026-02-19, Balance as of period end |
| 2024-12-31 | $555.03M | +15.1% | 2026-02-19, Balance as of period end |
| 2023-12-31 | $482.37M | -55.1% | 2025-02-20, Balance as of period end |
| 2022-12-31 | $1.07B | +49.8% | 2024-02-22, Balance as of period end |
| 2021-12-31 | $716.78M | +34.5% | 2023-02-23, Balance as of period end |
| 2020-12-31 | $532.76M | +9.3% | 2022-02-17, Balance as of period end |
| 2019-12-31 | $487.43M | -1.5% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $495.07M | +29.9% | 2020-02-25, Balance as of period end |
| 2017-12-31 | $381.17M | +134.4% | 2019-02-22, Balance as of period end |
| 2016-12-31 | $162.59M | -42.5% | 2019-02-22, Balance as of period end |
| 2015-12-31 | $282.88M | +77.7% | 2018-02-23, Balance as of period end |
| 2014-12-31 | $159.23M | +39.8% | 2017-02-23, Balance as of period end |
| 2013-12-31 | $113.89M | +25.5% | 2016-02-25, Balance as of period end |
| 2012-12-31 | $90.78M | +511.4% | 2015-02-27, Balance as of period end |
| 2011-12-31 | $14.85M | +38.2% | 2014-03-06, Balance as of period end |
| 2010-12-31 | $10.74M | n/a | 2012-03-13, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Insmed Inc (INSM) | 2025-12-31 | $510.44M | -8.0% |
| Opko Health, Inc. (OPK) | 2025-12-31 | $364.41M | -14.6% |
| TG Therapeutics, Inc. (TGTX) | 2025-12-31 | $79.15M | -56.0% |
| Axsome Therapeutics, Inc. (AXSM) | 2025-12-31 | $322.93M | +2.4% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $93.68M | -30.9% |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $71.33M | -53.7% |
| Ultragenyx Pharmaceutical Inc. (RARE) | 2025-12-31 | $421.00M | +142.0% |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $165.60M | -9.8% |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $296.68M | +33.3% |
Compare INSM, OPK, TGTX, AXSM side by side · Screen every company in Pharmaceutical Preparations ↗